✦ LIBER ✦

Pemetrexed versus docetaxel in second line non-small-cell lung cancer: Results and subsets analyses of a multi-center, randomized, exploratory trial in Chinese patients

✍ Scribed by Rui Li; Li Sun; Jiejun Wang; Jianxin Qian; Zhan Wang; Xiaodong Jiao

Book ID: 118495644
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 162 KB
Volume: 25
Category: Article
ISSN: 1094-5539
DOI: 10.1016/j.pupt.2012.06.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase III Trial of Pemetrexed

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

✍ Hanna, N.; Shepherd, F. A.; Fossella, F. V.; Pereira, J. R.; De Marinis, F.; von 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 229 KB

A Randomized Phase II Trial of Oral Topo

A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer

✍ Suzanne Jones; Dana Thompson; John Barton; Jeff Patton; Dianna Shipley; F. Antho 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 124 KB

Pemetrexed Versus Pemetrexed and Carbopl

Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial

✍ Ardizzoni, A.; Tiseo, M.; Boni, L.; Vincent, A. D.; Passalacqua, R.; Buti, S.; A 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 200 KB

Preliminary results of a phase II random

Preliminary results of a phase II randomized trial of docetaxel vs vinorelbine as second-line treatment in previously cisplatin-treated advanced non-small cell lung cancer (NSCLC)

✍ Marangolo, M; Cognetti, F; Di Costanzo, F; Selvaggi, G; Scagliotti, G.V 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB

O-091 A randomized phase II trial of doc

O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer

✍ Robinet, G.; Falchero, L.; Perol, M.; Thomas, P.; Monnet, I.; Grivaux, M.; Crequ 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Quality of life assessment of second-lin

Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial

✍ Dancey, J 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 178 KB